Loading…
Privia Health Group, Inc. is projected to rise to $30.71 by 2027, a +29% move from its current price of $23.86. PRVA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $23.46 | $23.86 | $24.27 | 0.00% |
| Aug 2 | $23.29 | $23.86 | $24.44 | -0.01% |
| Aug 3 | $23.16 | $23.86 | $24.57 | -0.01% |
| Aug 4 | $23.05 | $23.86 | $24.68 | -0.02% |
| Aug 5 | $22.96 | $23.85 | $24.78 | -0.02% |
| Aug 6 | $22.88 | $23.85 | $24.87 | -0.03% |
| Aug 7 | $22.80 | $23.85 | $24.95 | -0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $22.80 | $23.85 | $24.95 | -0.03% |
| Week 2 | $22.37 | $23.84 | $25.42 | -0.07% |
| Week 3 | $22.04 | $23.84 | $25.77 | -0.10% |
| Week 4 | $21.77 | $23.83 | $26.08 | -0.14% |
| Week 5 | $21.53 | $23.82 | $26.35 | -0.17% |
| Week 6 | $21.32 | $23.81 | $26.60 | -0.21% |
| Week 7 | $21.12 | $23.80 | $26.82 | -0.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems, and it offers technology and population health tools to enhance providers’ workflows.
It provides a management services organization that enables providers to focus on their patients by reducing administrative work, and a single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. Privia Health also operates an accountable care organization that engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care; and a network for purchasers and payers that enables providers to connect across platforms to address the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.
In addition to its core physician-enablement platform, Privia Health sits within the Healthcare sector, delivering services designed to improve care coordination and value-based outcomes for providers and payers alike.
Privia Health Group, Inc. (PRVA) is a healthcare-services company operating as a national physician-enablement platform in the United States. It trades with a current price of $24.97 and carries a market capitalization of $3.15B, holding a rank of 1669 among exchange-listed assets.
The current price sits near the 50-day moving average and is accompanied by a bullish but measured technical backdrop. The forecast path shows upside from 2026 onward, with higher average prices projected through 2030, 2040, and 2050, suggesting meaningful long-run appreciation despite near-term volatility.
In 2026 the forecast assigns an average price of $24.97 with neutral sentiment, providing a starting point that aligns with the current price. From 2027 onward, the model envisions a continuing climb in average prices and expanding upside potential, culminating in multi-year highs by 2040 and beyond.
A major floor 16.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.9% away) — a key level to hold.
The nearest ceiling, 17.8% above — a clean break opens room to run.
A major ceiling 25.0% above — clearing it would confirm fresh momentum.
Key PRVA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PRVA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $24.60 | Sell | $24.51 | Sell |
| MA 10 | $25.28 | Sell | $25.13 | Sell |
| MA 20 | $26.41 | Sell | $25.50 | Sell |
| MA 50 | $24.40 | Sell | $24.90 | Sell |
| MA 100 | $23.55 | Buy | $24.18 | Sell |
| MA 200 | $23.65 | Buy | $23.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.92 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -143.85 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.48 | Sell |
| ROC (12) | -14.88 | Sell |
| Bollinger %B (20,2) | 0.02 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | -0.95 | Sell |
| Ultimate (7,14,28) | 23.65 | Buy |
| Momentum (10) | -3.36 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 23.99 | Sell |
| ADX (14) | 28.16 | Sell |
| ATR (14) | 0.43 | Info |
The 30-day technical picture shows a bullish tilt with its near-term trajectory supported by key levels. The price has traded within a 30-day range of $22.40 to $27.84, indicating a constructive but cautious range-bound dynamic.
The stock’s RSI (14) sits at 40, slightly below the midpoint, and the 50-day simple moving average is $24.25 while the 200-day simple moving average is $23.64, placing the price above both moving averages. Support is reported at $22.90 and resistance at $28.10, framing a modest upside potential over the short term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $20.02 | $23.86 | $29.85 | 0% | Neutral | |
| $25.18 | $30.71 | $39.14 | +29% | Bullish | |
| $31.57 | $39.24 | $51.38 | +64% | Bullish | |
| $32.76 | $41.34 | $55.30 | +73% | Bullish | |
| $35.88 | $45.90 | $62.52 | +92% | Bullish | |
| $38.91 | $50.39 | $69.72 | +111% | Bullish | |
| $40.11 | $52.53 | $73.72 | +120% | Bullish | |
| $48.39 | $64.04 | $91.04 | +168% | Bullish | |
| $55.20 | $73.79 | $106.16 | +209% | Bullish | |
| $58.71 | $79.23 | $115.25 | +232% | Bullish | |
| $88.50 | $124.57 | $189.94 | +422% | Bullish | |
| $144.19 | $217.69 | $355.83 | +812% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $20.02 | $23.86 | $27.78 | +0.00% |
| August 2026 | $20.19 | $23.54 | $27.97 | -1.35% |
| September 2026 | $20.26 | $23.75 | $28.49 | +0.91% |
| October 2026 | $20.78 | $24.48 | $29.58 | +3.04% |
| November 2026 | $20.70 | $24.48 | $29.76 | +0.03% |
| December 2026 | $20.58 | $24.42 | $29.85 | -0.25% |
Click any year to see its month-by-month PRVA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PRVA price prediction for 2026 points to an average of $23.86 (low $20.02, high $29.85) — a potential gain of 0% on today's $23.86. Price action looks broadly range-bound.
In 2027, PRVA is projected to trade between $25.18 and $39.14, averaging $30.71 — a potential gain of +29% from today's $23.86. That is up +29% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Privia Health Group, Inc.'s 2028 outlook centres on $39.24, within a $31.57 to $51.38 range. That is up +28% on the projected 2027 average. That marks a +64% change versus current levels. Momentum favours further upside here.
By 2029, PRVA could reach as high as $55.30, with a base case around $41.34 and support toward $32.76 — roughly +73% from $23.86. Buyers look set to stay in control over this stretch.
Expect PRVA to range from $35.88 to $62.52 through 2030. The $45.90 average target implies a +92% move from current prices. That is up +11% on the projected 2029 average. Momentum favours further upside here.
The PRVA price prediction for 2031 points to an average of $50.39 (low $38.91, high $69.72) — a potential gain of +111% on today's $23.86. Buyers look set to stay in control over this stretch.
In 2032, PRVA is projected to trade between $40.11 and $73.72, averaging $52.53 — a potential gain of +120% from today's $23.86. That is up +4% on the projected 2031 average. Momentum favours further upside here.
Privia Health Group, Inc.'s 2033 outlook centres on $64.04, within a $48.39 to $91.04 range. That is up +22% on the projected 2032 average. That marks a +168% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, PRVA could reach as high as $106.16, with a base case around $73.79 and support toward $55.20 — roughly +209% from $23.86. Momentum favours further upside here.
Expect PRVA to range from $58.71 to $115.25 through 2035. The $79.23 average target implies a +232% move from current prices. That is up +7% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The PRVA price prediction for 2040 points to an average of $124.57 (low $88.50, high $189.94) — a potential gain of +422% on today's $23.86. Momentum favours further upside here.
In 2050, PRVA is projected to trade between $144.19 and $355.83, averaging $217.69 — a potential gain of +812% from today's $23.86. That is up +75% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PRVA today (≈ 41.911148 PRVA) could be worth
$9,123.67
+$8,123.67 (+812%) by 2050 · US Dollar
Based on the average projected PRVA price of $217.69 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PRVAwould be worth at today's price.
$1,000 invested in PRVA on Jul 30, 2025 (≈ 51.046452 PRVA) would be worth
$1,217.97
+$217.97 (+21.8%) today · 1.22× · US Dollar
Based on a PRVA entry price of $19.59 vs. today's $23.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $24.97 | $955.55 | -4.4% |
| 1 month ago | $25.73 | $927.32 | -7.3% |
| 3 months ago | $24.85 | $960.16 | -4.0% |
| 6 months ago | $23.22 | $1,027.56 | +2.8% |
| 1 year ago | $19.59 | $1,217.97 | +21.8% |
| All time (5.0y) ago | $41.59 | $573.7 | -42.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PRVA forecast.
Our base-case forecast reaches $48.00 around 2031.
Implied market cap at $48.00: $6.05B
The multi-year forecast projects a clear bullish path with progressively higher averages and sizable upside over time. In 2027 the average is projected to $33.05 with a bullish sentiment and a 32.4% implied return on investment. By 2028, the average rises to $41.97 with an 68.1% ROI, and in 2029 the average is $44.65 with an 78.8% ROI.
By 2030 the forecast envisions an average of $50.03 with a 100.4% ROI and a bullish sentiment, continuing higher in 2031 to an average of $54.99 (120.2% ROI) and 2032 to $58.00 (132.3% ROI). The path extends to 2033 with an average of $71.38 (185.9% ROI) and 2034 at $81.95 (228.2% ROI), then 2035 at $88.57 (254.7% ROI).
Further out, the forecast signals substantial gains: by 2040 the average is $140.78 with a 463.8% ROI, and by 2050 the average is $251.29 with a 906.4% ROI, both under bullish sentiment. These figures imply meaningful long-run appreciation, though they are estimates rather than guarantees and are subject to market and sector dynamics.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $50.03 with a maximum of $68.16 and a minimum of $39.10, accompanied by a 100.4% ROI and a bullish sentiment.
The long-run forecast is bullish, with rising average prices and positive ROIs from 2027 onward (e.g., 2027 avg $33.05, 2028 $41.97, 2030 $50.03, 2040 $140.78, 2050 $251.29). However, 2026 is neutral at an average of $24.97, and these are estimates, not guarantees.
Yes. The forecast shows the 2040 average at $140.78, well above $100, indicating the path to higher price levels exists by the mid-2030s to 2040 timescale.
The 30-day range is $22.40 to $27.84, RSI (14) is 40, SMA50 is $24.25, SMA200 is $23.64, with support at $22.90 and resistance at $28.10.
The current price is $24.97 and the market cap is $3.15B, with a rank of 1669.
Privia Health Group, Inc. Community Discussion
0Share your Privia Health Group, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.